Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
0.7463 USD | +7.85% | -2.74% | -1.35% |
Kurzporträt
Mitarbeiterzahl: 22
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Leonard Mazur
CEO | Chief Executive Officer | 79 | 01.07.13 |
Jaime Bartushak
DFI | Director of Finance/CFO | 57 | 27.11.17 |
Preeti Singh
CTO | Chief Tech/Sci/R&D Officer | - | 01.01.22 |
Myron Czuczman
CTO | Chief Tech/Sci/R&D Officer | 65 | 14.07.20 |
Alan Lader
CTO | Chief Tech/Sci/R&D Officer | - | 01.03.16 |
Gary Talarico
COO | Chief Operating Officer | 69 | 01.03.16 |
Myron Holubiak
BRD | Director/Board Member | 77 | 01.10.15 |
Ilanit Allen
IRC | Investor Relations Contact | - | 17.05.21 |
General Counsel | - | 10.02.22 | |
Paul Sowyrda
PRN | Corporate Officer/Principal | - | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Myron Holubiak
BRD | Director/Board Member | 77 | 01.10.15 |
Dennis McGrath
BRD | Director/Board Member | 67 | 07.02.23 |
Leonard Mazur
CEO | Chief Executive Officer | 79 | 01.07.13 |
Carol Webb
BRD | Director/Board Member | 78 | 01.03.16 |
Suren Dutia
BRD | Director/Board Member | 82 | 01.10.15 |
Eugene Holuka
BRD | Director/Board Member | 65 | 01.06.16 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 180 395 150 | 168 087 211 ( 93,18 %) | 0 | 93,18 % |
Unternehmenskontakt
Citius Pharmaceuticals, Inc.
11 Commerce Drive 1st floor
07016, Cranford
+908 967 6677
http://www.citiuspharma.comSektor
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
-1.35% | 135 Mio. | |
+0.17% | 42.19 Mrd. | |
+44.30% | 40.15 Mrd. | |
-6.20% | 28.31 Mrd. | |
+5.23% | 24.63 Mrd. | |
-24.79% | 18.2 Mrd. | |
+26.69% | 12.01 Mrd. | |
-3.13% | 11.76 Mrd. | |
+6.57% | 10.4 Mrd. | |
-18.08% | 9.94 Mrd. |
- Börse
- Aktien
- A2DXS0 Aktie
- Unternehmen Citius Pharmaceuticals, Inc.